De Lorenzo et al. collected clinical data of hospitalized COVID-19 patients, divided individuals into a group of patients with mild to moderate outcome and with severe even fatal outcome, performed ROC analyses using levels of sGFAP, sNFL and serum total tau (sT-tau), and concluded that levels of these three serum indicators all were elevated [77]. This evidence concerns the gene MAPT and COVID-19.